A5085336375- MicroRNA in disease regulation
- Neuropeptides and Animal Physiology
- Gout, Hyperuricemia, Uric Acid
- Cancer, Stress, Anesthesia, and Immune Response
- Liver Disease Diagnosis and Treatment
- Inflammatory mediators and NSAID effects
- Extracellular vesicles in disease
- Circular RNAs in diseases
- Inflammasome and immune disorders
General Hospital of Jinan Military Command
2015
Rationale: Extracellular vesicles (EVs) have emerged as novel mediators of cell-to-cell communication that are capable the stable transfer therapeutic microRNAs (miRNAs), and thus, EVs hold immense promise a miRNA delivery system for cancer therapy. Additionally, miRNA-containing secreted into circulation, miRNAs contained within plasma may represent ideal biomarkers diseases. The objective this study was to characterize potential tumor suppressor miRNA, miR-101, explore miR-101 via in vivo...
This study was designed to evaluate the clinical efficacy of controlled-release morphine tablets combined with celecoxib in relieving osteocarcinoma-related pain and effects combination on WNK1 expression.A total 110 patients were selected divided into two groups based treatment administered, including control group (treated alone) a celecoxib). We compared efficacy, level (visual analog scale (VAS)), time onset breakthrough (BTP), dose morphine, incidence adverse events, quality life (QOL)...